You are here

Cognetivity Neurosciences Ltd.

Cognetivity Neurosciences Ltd.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
CGN
CSE Index: 
Currency: 

Cognetivity Neurosciences Ltd. is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA) for use in medical and commercial environments. Cognetivity’s ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain, potentially allowing early diagnosis of dementia. Cognetivity aims to develop the ICA through planned clinical studies to the market in North America and Europe.

You are here

Cognetivity Neurosciences Ltd. (CGN)

SEDAR Information

Company Info

Address
Suite 1430, 800 West Pender Street
VANCOUVER, BC V6C 2V6
Canada
Phone
604 363 0411
Email
kevin@calibrecapital.ca
Website
http://www.cognetivity.com
Listing date
Monday, March 19, 2018
Transfer Agent
TSX Trust Company

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
84,214,972
Reserved for Issuance: 
18,286,051

Bulletins

15/03/2018

2018-0316 – New Listing – Cognetivity Neurosciences Ltd. (CGN)

Le 15 mars/March 2018

The common shares of Cognetivity Neurosciences Ltd. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the listing date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

Benzinga Cannabis Capital Conference

Benzinga Cannabis Capital Conference

Tuesday, April 11, 2023 - 8:00am to Wednesday, April 12, 2023 - 5:00pm